Skip to content
Topics
Obesity/Cancer FAQs
General News
Gastroparesis
Learn about Lipids
Obese vs Non-Obese
Obesity Drugs
Semaglutide
Tirzepatide
Obesity Drugs in the Pipeline
Lawsuits
Bariatric Surgery
Grants
Addiction
Journals/References/Books
Clinical Trials
Clinical Trials – United States
Clincal Trials – ExUS
Breast Cancer-Obesity Clinical Trials
FDA
Conferences
Conference Updates
Institutions
Blog Posts / News
Login
News Archive
Posts Archive
Guest Post
Author’s Registration Page
Author’s Post Page
Bloggers
Related Cancers
Breast
Colon & Rectum
Kidney
Endometrium
Pancreas
Thyroid
Liver
Multiple Myeloma
Upper Stomach
Meningioma
Adenocarcinoma of the Esophagus
Ovary
Gallbladder
Pediatric
Mesothelioma
About
Contact
Topics
Obesity/Cancer FAQs
General News
Gastroparesis
Learn about Lipids
Obese vs Non-Obese
Obesity Drugs
Semaglutide
Tirzepatide
Obesity Drugs in the Pipeline
Lawsuits
Bariatric Surgery
Grants
Addiction
Journals/References/Books
Clinical Trials
Clinical Trials – United States
Clincal Trials – ExUS
Breast Cancer-Obesity Clinical Trials
FDA
Conferences
Conference Updates
Institutions
Blog Posts / News
Login
News Archive
Posts Archive
Guest Post
Author’s Registration Page
Author’s Post Page
Bloggers
Related Cancers
Breast
Colon & Rectum
Kidney
Endometrium
Pancreas
Thyroid
Liver
Multiple Myeloma
Upper Stomach
Meningioma
Adenocarcinoma of the Esophagus
Ovary
Gallbladder
Pediatric
Mesothelioma
About
Contact
Search
Related Cancers
Cancer & Obesity Reviews (20 of the most recent)
Obesity-cancer axis crosstalk: Molecular insights and therapeutic approaches
July 14, 2025
Now recognized as a global health crisis, obesity has been linked to an increased risk of many types of cancer, including those of the breast, colon, rectum, uterus, gallbladder, and ovary. Obesity and cancer share several characteristics at the cellular, molecular, and epigenetic levels. Obesity is characterized by chronic inflammation of the adipose tissue (AT), […]
Ahmed Rakib
Comparative outcomes of intracorporeal and extracorporeal anastomosis following laparoscopic colectomy in patients with obesity with Colon cancer
July 11, 2025
CONCLUSION: The study revealed that in patients with obesity, IA resulted in faster bowel function recovery, shorter hospital stays, and fewer complications. Furthermore, IA produced better pathological outcomes, characterized by longer specimen lengths and wider safety margins, without compromising 3-year overall and disease-free survival rates. Thus, IA is a safe and feasible anastomosis technique for […]
Feng-Ching Tsai
The impact of sarcopenic obesity on cancer clinical outcomes
July 10, 2025
Sarcopenic obesity is a distinct clinical condition characterized by the coexistence of excess fat and reduced muscle mass. Although the prevalence of sarcopenic obesity varies depending on the definition used, it is increasingly recognized as a significant health concern, regardless of age and underlying disease. Despite limited understanding of the crosstalk between sarcopenic obesity and […]
Bahadır Köylü
Editorial special issue: Frontiers in cancer, obesity and metabolism
July 4, 2025
This Special Issue contains 7 contributions elaborated in the context of the workshop "Frontiers in Cancer, Obesity and metabolism" organized by the Journal of Physiology and Biochemistry (Pamplona, Spain, 2022). It contains basic, translational and epidemiological research that sheds light in our understanding of the molecular mechanisms underlying how the excess of adipose tissue in […]
Ana B Crujeiras
Adipose-Derived Stem Cells at the Crossroads of Obesity and Cancer
July 3, 2025
Obesity is a major concern for public health and is associated with a higher risk of various types of cancer. Understanding the fundamental mechanisms of this relationship is essential for effective cancer prevention and treatment. Adipose-derived stem cells (ADSCs) are a specialized subtype of mesenchymal stem cells (MSCs) extracted from adipose tissue. These cells have […]
Ahmad Reza Panahi Meymandi
SREBP-1 in obesity-induced breast cancer: mechanisms and therapeutic perspectives
July 2, 2025
Breast cancer is the most prevalent form of malignant cancer among women worldwide, and obesity is a significant risk factor. Sterol regulatory element-binding protein 1 (SREBP-1) is a crucial transcription factor that governs lipid synthesis and is aberrantly activated in obesity-induced breast cancer. This review examines the intricate relationship between SREBP-1, obesity, and breast cancer, […]
Urvashi Tiwari
Wound Complications in Patients with Overweight, Obesity, and Gynecologic Cancer: A Retrospective Analysis of Staple Versus Suture Closure
July 1, 2025
Background: Wound complications in gynecologic oncology, especially among patients with overweight and obesity, can significantly impact post-operative recovery and delay the initiation of adjuvant treatment. Although staples are commonly used for vertical incisions, sutures may offer clinical advantages; however, direct comparative data remain limited. This study aimed to compare post-operative wound complication rates between staples […]
Fatma Ceren Güner
Understanding the role of obesity in endocrine therapy for postmenopausal breast cancer: significance of the BIG 1-98 and ATAC trial data
July 1, 2025
Obesity is a known risk factor for poor breast cancer outcomes, but its impact on endocrine therapy efficacy remains unclear. While the ATAC trial suggests reduced effectiveness of aromatase inhibitors (AIs) in women with obesity, the BIG 1-98 trial found no significant differences. Clinical and biological evidence indicates that obesity may impair AI efficacy by […]
Sixten Harborg
Navigating the weight: The impact of obesity on gastrointestinal cancer surgery and strategies for improved outcomes
June 28, 2025
Obesity significantly affects gastrointestinal cancer surgery outcomes by creating complex challenges throughout the preoperative, intraoperative, and postoperative stages. This narrative review explores the intricate relationship between obesity and GIC surgery, highlighting the dual burden of obesity as a global public health issue and a determinant of surgical complications. The review aims to analyze physiological and […]
Gerardo Sarno
How Obesity Complicates Breast Cancer Care: Insights From a Systematic Review of Case Reports
June 26, 2025
The global rise in obesity has intersected with increasing breast cancer incidence, generating a critical need to understand how excess adiposity affects diagnostic accuracy, treatment delivery, and patient outcomes. Although large epidemiologic studies have established associations between obesity and worse breast cancer prognosis, individual-level clinical nuances remain underrepresented. This review systematically evaluates case-based evidence to […]
Adam M Bowen
The Relationship Between Obesity and Cancer: Epidemiology, Pathophysiology, and the Effect of Obesity Treatment on Cancer
June 25, 2025
There is growing evidence relating to the risk of cancer in people with obesity. Obesity is already established as one of the strongest predisposing factors to cancer, and 'obesity-related' cancers have been defined in previous studies. In this review article, we examine the epidemiological relationship and describe the potential pathophysiological mechanisms that underpin the association […]
Yasmin Ingram
Obesity and cancer: unravelling the microbiome's hidden role
June 24, 2025
Obesity has been implicated as the driving force of many diseases including cancer through multiple biological mechanisms, including gut microbial imbalances, compromised intestinal barrier integrity, persistent low-grade inflammation, and alterations in energy uptake. As lifestyle factors such as diet, physical activity, and sleep are known to influence disease susceptibility, understanding the role of the gut […]
Christine Gaskell
Complex Interplay Between Obesity and BRCA1/2-Associated Breast Cancer: An Overview
June 16, 2025
The steadily increasing prevalence of obesity and its association with a growing number of malignancies, including breast cancer, has made this disease spectrum an urgent and critical public health priority, demanding immediate attention and comprehensive action. To date, a growing body of research has been dedicated to the study of obesity/breast cancer biological link, with […]
Cinzia Giordano
Thematic issue: Obesity-driven cancer: Clinical and molecular aspects
June 15, 2025
Obesity-associated insulin resistance (IR) is characterized by a chronic low-grade inflammatory state driven by adipocyte dysfunction, elevated free fatty acids, and proinflammatory cytokines. These factors activate signaling pathways-including JNK, TLR, and NF-κB-that impair insulin receptor function and promote hyperinsulinemia. Elevated insulin reduces insulin-like growth factor binding proteins, thereby increasing the bioavailability of IGF-1 and IGF-2, […]
Emmanuel Jacobo-Tovar
Murine Models of Obesity-Related Cancer Risk
June 13, 2025
Obesity is a global menace that has impacted over 14% of adults worldwide and over a third of Americans. Importantly, obesity is associated with an increased risk of over 13 types of cancer and worse outcomes, including increased mortality. This review focuses on the importance of considering obesity and metabolic dysfunction in cancer risk as […]
Lukmon M Raji
Weighty matters: Unraveling the impact of obesity on colorectal cancer and nutritional interventions
June 7, 2025
This narrative review explores the influence of obesity on colorectal cancer, focusing on obesity-related factors, including chronic inflammation, metabolic dysregulation, and gut microbiota imbalance, which collectively create a pro-carcinogenic environment that increases colorectal cancer risk and complicates treatment outcomes. The findings indicate that obesity not only accelerates tumor progression but also presents challenges in colorectal […]
Daniel Simancas-Racines
"Time" for obesity-related cancers: The role of chrononutrition in cancer prevention and treatment
June 5, 2025
Obesity-related cancers are increasing globally, driven by metabolic disturbances and circadian rhythm disruptions. Circadian rhythms regulate physiological processes, and their misalignment has been linked to increased cancer risk. Chrononutrition, which aligns dietary intake with the body's circadian clock, has emerged as a potential strategy for cancer prevention and treatment. This review explored the intricate relationship […]
Ludovica Verde
Impact of Obesity on Cancer-Specific Survival and Overall Survival in Colorectal Cancer
June 4, 2025
Obesity is a well-established risk factor for colorectal cancer (CRC) development, yet its influence on cancer-specific survival (CSS) and overall survival (OS) remains paradoxical. While obesity correlates with adverse outcomes such as increased recurrence, metastasis, and treatment-related complications, emerging evidence highlights a counterintuitive "obesity paradox," where overweight and moderately obese patients with Body Mass Index(BMI […]
Elvis Obomanu
Epitranscriptomic Role of m6A in Obesity-Associated Disorders and Cancer Metabolic Reprogramming
May 28, 2025
The global rise in obesity and its associated metabolic disorders underscores the need for a deeper investigation into their underlying molecular mechanisms. While genetic factors are well-established contributors, recent research has increasingly focused on epigenetic regulators, particularly N6-methyladenosine (m⁶A)-the most prevalent internal RNA modification in eukaryotes. This post-transcriptional modification plays a crucial role in RNA […]
Sujun Yan
The correlation between obesity and the occurrence and development of breast cancer
May 25, 2025
This study reviews the mechanisms by which obesity affects the development and progression of breast cancer (BC). The association between obesity and BC is mainly due to three aspects: disruption of glycolipid metabolism, abnormal cell function and imbalance of adipokine levels. The dysregulation of glycolipid metabolism caused by obesity, including the accumulation of cholesterol and […]
Jun-Jie Hu
Prevalence of Obesity-Associated Cancers in the United States
Rate of new obesity-associated cancers in the United States from 2016 to 2020 by state.
Rate of new obesity-associated cancers in the United States from 2016 to 2020, by cancer type.
Rate of new obesity-associated cancers in the United States from 2016 to 2020, by race and ethnicity.
Cancer Types
Breast
Thyroid
Adenocarcinoma of the esophagus
Colon & Rectum
Liver
Ovary
Kidney
Multiple Myeloma
Gallbladder
Endometrium
Upper Stomach
Pancreas
Meningioma